Literature DB >> 16105937

Role of leptin in obesity-related hypertension.

William G Haynes1.   

Abstract

Obesity in humans causes hypertension, myocardial hypertrophy and coronary atherosclerosis, and increased cardiovascular morbidity and mortality that is thought to be related to sympathetic overactivity. Leptin is an adipocyte-derived hormone that acts in the hypothalamus to regulate appetite, energy expenditure and sympathetic nervous system outflow. One of the major mechanisms leading to the development of obesity-induced hypertension appears to be leptin-mediated sympatho-activation. Leptin adversely shifts the renal pressure-natriuresis curve, leading to relative sodium retention. Although obesity is generally associated with resistance to the anorexic and weight-reducing actions of leptin, our work has shown preservation of its sympatho-excitatory and pressor actions. This selective leptin resistance of obesity, coupled with hyperleptinaemia, may play a critical role in the cardiovascular complications of obesity. Increased information about leptin and its mechanisms of actions should help the development of safe and effective pharmacological treatments of obesity and obesity-related hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105937     DOI: 10.1113/expphysiol.2005.031237

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  26 in total

Review 1.  Cardiovascular effects of leptin.

Authors:  Gary Sweeney
Journal:  Nat Rev Cardiol       Date:  2009-12-01       Impact factor: 32.419

Review 2.  Blood pressure variability: assessment, predictive value, and potential as a therapeutic target.

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

Review 3.  Sympathoinhibitory signals from the gut and obesity-related hypertension.

Authors:  Daniela M Sartor
Journal:  Clin Auton Res       Date:  2012-07-13       Impact factor: 4.435

Review 4.  Assessment and management of blood-pressure variability.

Authors:  Gianfranco Parati; Juan E Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

5.  Circulating leptin is associated with serum uric acid level and its tubular reabsorption in a sample of adult middle-aged men.

Authors:  L D'Elia; A Giaquinto; F P Cappuccio; R Iacone; O Russo; P Strazzullo; F Galletti
Journal:  J Endocrinol Invest       Date:  2019-11-05       Impact factor: 4.256

Review 6.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

Review 7.  Blood pressure variability, cardiovascular risk, and risk for renal disease progression.

Authors:  Gianfranco Parati; Juan E Ochoa; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 8.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Authors:  Seth S Martin; Atif Qasim; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

9.  Slow prenatal growth and accelerated postnatal growth: critical influences on adult blood pressure.

Authors:  Barbara T Alexander; Norma B Ojeda
Journal:  Hypertension       Date:  2008-09-02       Impact factor: 10.190

10.  Adipokines, insulin resistance, and coronary artery calcification.

Authors:  Atif Qasim; Nehal N Mehta; Mahlet G Tadesse; Megan L Wolfe; Thomas Rhodes; Cynthia Girman; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-07-15       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.